Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis

Publication

dc.contributor.author	Oliveira, A.
dc.contributor.author	Bretes, L.
dc.contributor.author	Furtado, I.
dc.date.accessioned	2017-04-07T15:56:33Z
dc.date.available	2017-04-07T15:56:33Z
dc.date.issued	2016-07
dc.description.abstract	Introduction: Selection of first line treatment for patients with metastatic colorectal cancer (mCRC) is based on tumour and patient related factors. The wide and increasingly use of targeting agents in this setting are proven to be beneficial in first line treatment. Increasing evidence suggests that this first line treatment is of great importance and its impact is being studied in prospective studies. In this retrospective analysis, we aimed to analyze the first treatment used and its potential impact on overall survival (OS).
dc.identifier.doi	https://doi.org/10.1093/annonc/mdw199.157
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10400.1/9450
dc.language.iso	eng
dc.peerreviewed	yes
dc.publisher	Oxford University Press
dc.relation.isbasedon	WOS:000379756200158
dc.title	Choice of first line treatment and survival in metastatic colorectal cancer: a retrospective analysis
dc.type	journal article
dspace.entity.type	Publication
oaire.citation.conferencePlace	Barcelona, Spain
oaire.citation.endPage	48
oaire.citation.startPage	48
oaire.citation.title	Annals of Oncology
oaire.citation.volume	27
rcaap.rights	openAccess
rcaap.type	article

Files

Now showing 1 - 1 of 1